← Open Payments lookup

KIMBERLY BROWN: Open Payments

NPI 1508934035 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$157,021 in 69 payments from 9 companies in 2025. Trend: 2023 $130,432 · 2024 $133,894 · 2025 $157,021

Speaker / faculty: $104,847Consulting: $38,670Travel & lodging: $6,485Speaker / faculty: $4,960Food & beverage: $2,060
CompanyPaymentsAmount
Madrigal Pharmaceuticals21$45,482
Gilead Sciences, Inc.24$45,218
Mallinckrodt Hospital Products Inc.8$29,109
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$20,440
Intercept Pharmaceuticals, Inc.4$7,339
Ipsen Biopharmaceuticals, Inc1$4,590
GlaxoSmithKline, LLC.1$4,000
Bausch Health US, LLC1$800
Boston Scientific Corporation2$44

Products named: REZDIFFRA, TERLIVAZ, Livdelzi, Epclusa, XIFAXAN, OCALIVA, Vemlidy, IQIRVO.

Industry payments across MI — which companies pay providers there.